Mizuho’s Jared Holz on what is next for Sarepta after second death connected to gene therapy

Mizuho’s Jared Holz on what is next for Sarepta after second death connected to gene therapy

June 16, 2025

Jared Holz, Mizuho, joins ‘Fast Money’ to talk the fallout for Sarepta after another death related to its muscular dystrophy gene therapy.

Share This

Latest Mizuho News

Nvidia is the most compelling tech stock you can buy right now, says Mizuho’s Jordan Klein

Nvidia is the most compelling tech stock you can buy right now, says Mizuho’s Jordan Klein

November 18, 2025

VR has been ‘pretty big disappointment’ for Meta, says Mizuho’s Lloyd Walmsley

VR has been ‘pretty big disappointment’ for Meta, says Mizuho’s Lloyd Walmsley

December 4, 2025

Walmart lifts full-year outlook, warns of higher costs

Walmart lifts full-year outlook, warns of higher costs

November 20, 2025

Mizuho news from around the globe

Mizuho Global News